Jme Group Inc
JME Group, Inc. is a privately held, biotechnology company founded on March 2014 in New Jersey, U.S. The company embarked on a project to develop and commercialize a safer and affordable enzyme replacement therapy (ERT) for metabolic and lysosomal storage diseases (a group of rare (orphan) diseases deficient in lysosomal enzymes) via oral administration (hence Oral-ERT) using plant-derived recombinant human enzymes or proteins plus natural non-GMO plant products for improvement of human and animal health. The first enzyme in the pipeline using this platform is a recombinant human lysosomal acid alpha-glucosidase (GAA) or acid maltase produced in tobacco seeds for the treatment of acid maltase deficiency (AMD or POMPE disease).
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Jme Group Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Jme Group Inc
2 distinct titles indexed · top 2 shown.
- 1owner and ceo
- 1vp reasearch
Sign up to unlock all 2 contacts at Jme Group Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Jme Group Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.